Key result
Perioperative gabapentin shows comparable complications and heart failure rates to pregabalin in lumbar laminectomy.
Why the study?
Gabapentinoids are commonly used in multimodal analgesia for lumbar spine surgery, but the long-term cardiovascular safety of perioperative gabapentin versus pregabalin in elderly patients remained uncertain.
Does perioperative pregabalin versus gabapentin alter 90-day postoperative complications and two-year cardiovascular and surgical outcomes in patients aged 65 years or older undergoing one- to three-level lumbar laminectomy?
Cohort (n=1,488)
Does perioperative pregabalin versus gabapentin alter 90-day postoperative complications and two-year cardiovascular and surgical outcomes in patients aged 65 years or older undergoing one- to three-level lumbar laminectomy?
In geriatric patients undergoing lumbar laminectomy, perioperative pregabalin and gabapentin demonstrate comparable 90-day complication rates and two-year cardiovascular safety profiles.
Answers are grounded in this paper and cite their sources.
Comparable safety supports continued use of either agent; extends observational data but leaves open causal effects on cardiovascular outcomes.
Study Design: Retrospective propensity score-matched cohort study. Objective: To compare rates of 90-day postoperative complications and two-year cardiovascular and surgical outcomes between lumbar laminectomy patients aged 65 years or older receiving perioperative gabapentin versus pregabalin. Summary of Background Data: Patients undergoing lumbar spine surgery commonly experience substantial acute postoperative pain, which can negatively affect overall recovery and satisfaction. Gabapentinoids are common components of multimodal analgesia protocols, offering modest early analgesic and opioid-sparing effects with generally mild adverse effects. However, their long-term cardiovascular safety in the elderly remains uncertain. Materials and Methods: Using the PearlDiver Mariner 170 database, we identified beneficiaries aged 65 years or older who underwent one- to three-level lumbar laminectomy. Patients with perioperative fills (one month preoperatively to three months postoperatively) of gabapentin or pregabalin were included; long-term users, dual users, fusion procedures, and recent malignancy, infection, or trauma were excluded. We performed 3:1 (gabapentin:pregabalin) propensity score matching on demographics, comorbidities, and medications, and evaluated 90-day complications, two-year cardiovascular events, prolonged opioid use, and reoperation. Results: In the matched cohort of 372 pregabalin and 1116 gabapentin patients, 90-day complication rates, including readmission, delirium, respiratory failure, pulmonary complications, thromboembolic events, or acute kidney injury, were comparable. At two years, rates of primary heart failure (3.5% gabapentin vs. 5.1% pregabalin), myocardial infarction, arrhythmia, and stroke did not statistically differ. Both cohorts also exhibited comparable rates of prolonged opioid use and subsequent lumbar fusion. These outcomes remained consistent in the subgroup of patients with pre-existing cardiovascular disease. Conclusion: In this propensity-matched cohort of adults aged 65 years and older, we found that perioperative use of pregabalin and gabapentin was associated with comparable short-term complication rates and long-term cardiovascular outcomes following one- to three-level lumbar laminectomy. These results suggest that neither agent offers a definitive clinical advantage over the other with respect to perioperative safety or cardiovascular risk in this geriatric population.
No takes yet. Share an insight, caveat, or question.
Peterman et al. (2026) conducted a cohort in One- to three-level lumbar laminectomy / lumbar decompression (n=1,488). Perioperative gabapentin vs. Perioperative pregabalin was evaluated on 90-day postoperative complications and 2-year cardiovascular outcomes (including primary heart failure). Perioperative gabapentin vs pregabalin in older lumbar laminectomy patients showed comparable 90-day complications and 2-year heart failure rates.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: